Hjem › Parkinsons sykdom › Arizona
Kliniske studier for Parkinsons sykdom i Arizona
12 studier for Parkinsons sykdom søker deltakere på steder i Arizona.
Byer i Arizona
Offisiell studietekst (engelsk)
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- Banner Sun Health Research Institute, Sun City
RekruttererFase 2
Alder 40 til 80 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06680830A Study of Buntanetap in Participants With PD
- Banner Sun Health Research Institute - Cleo Roberts Center for Clinical Research, Sun City
RekruttererFase 2/3
Alder 40 til 85 · Alle kjønn · Oppdatert 21. sep. 2026 · NCT07284784A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #039, Scottsdale
- Vima Site #064, Scottsdale
RekruttererFase 2
Alder 18 til 65 · Alle kjønn · Oppdatert 11. sep. 2026 · NCT07804615Parkinson's Foundation PD GENEration Genetic Registry
- Barrow Neurological Institute, Phoenix
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 8. sep. 2026 · NCT04994015A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
- Banner Alzheimer's Institute (BAI)-Phoenix, Phoenix
- University of Arizona - Movement Disorder Clinic, Tucson
RekruttererObservasjonsstudie
Alder 45 til 75 · Alle kjønn · Oppdatert 4. sep. 2026 · NCT07330258Deep Brain Stimulation (DBS) Retrospective Outcomes Study
- St. Joseph's Hospital & Medical Center, Phoenix
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT03664609A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Barrow Neurological Institute, Phoenix
RekruttererFase 3
Alder 50 til 85 · Alle kjønn · Oppdatert 3. sep. 2026 · NCT07174310A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- Mayo Clinic Scottsdale - Neurology, Scottsdale
- Banner Sun Health Research Institute, Sun City
RekruttererFase 3
Alder 45 til 75 · Alle kjønn · Oppdatert 4. aug. 2026 · NCT06944522Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease
- University of Arizona, Tucson
Rekrutterer
Alder 22 til 80 · Alle kjønn · Oppdatert 31. jul. 2026 · NCT07207122PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- Barrow Neurological Institute, Phoenix
- Mayo Foundation for Medical Education and Research, Scottsdale
- Banner Research Institute, Sun City
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 30 og eldre · Alle kjønn · Oppdatert 27. jul. 2026 · NCT04477785A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
- Barrow Neurological Institute, Phoenix
RekruttererFase 4
Alder 18 og eldre · Alle kjønn · Oppdatert 24. aug. 2025 · NCT06765668TURN-IT FOG: Improving Turning and Freezing of Gait in People With PD
- Arizona State University, Tempe
Rekrutterer
Alder 50 til 80 · Alle kjønn · Oppdatert 28. jul. 2025 · NCT06815302Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.